DEL LABORATORIES INC

Del Laboratories Inc. (CIK 27751) operates as a clinical reference lab anchored in the medical laboratory cluster (SIC 8071) and builds its revenue on high-complexity diagnostics, customized chemistry panels, and therapeutic monitoring services for physicians, hospitals, and pharmaceutical partners needing rapid, accredited results. Its scientists package core offerings—immunoassays, molecular screens, toxicology, and specimen logistics—with digital reporting so community clinics and health systems can move from sample collection to treatment decisions without relying on distant university centers. The business is tethered to CLIA, HIPAA, and state licensing regimes that demand continuous validation of equipment, data security, and turnaround times, while reimbursement shifts, supplier dependencies for reagents, and any disruption from public health alerts pose material risks. Latest filing information is not yet available, so clients watch for updates as the company tracks compliance filings and patient volume trends. View live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025